My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Cabinet approves a new scheme for promotion of rural housing in the country
Jan 24,2017

The Union Cabinet chaired by the Prime Minister Narendra Modi has approved a new scheme for promotion of Rural Housing in the country. The Government would provide interest subsidy under the scheme. Interest subsidy would be available to every rural household who is not covered under the Pradhan Mantri Aawas Yojana (Grameen), PMAY(G).

The scheme would enable people in rural areas to construct new houses or add to their existing pucca houses to improve their dwelling units. The beneficiary who takes a loan under the scheme would be provided interest subsidy for loan amount upto Rs. 2 Lakhs.

National Housing Bank would implement the scheme. The Government would provide net present value of the interest subsidy of 3 percent to the National Housing Bank upfront which will, in turn, pass it to the Primary Lending Institutions (Scheduled Commercial Banks, NBFCs etc.). As a result the equated monthly installment (EMI) for the beneficiary would be reduced.

Under the scheme, the Government would also take necessary steps for proper convergence with PMAY-G including technical support to beneficiary through existing arrangements. The new scheme is expected to improve housing stock in the rural areas, as well as create employment opportunities in rural housing sector.

Powered by Capital Market - Live News

Lupin gains after launch of generic drug in US
Jan 24,2017

The announcement was made during market hours today, 24 January 2017.

Meanwhile, the S&P BSE Sensex was up 188.29 points or 0.69% at 27,305.63.

On the BSE, 21,000 shares were traded on the counter so far as against the average daily volumes of 79,217 shares in the past one quarter. The stock had hit a high of Rs 1,501 and a low of Rs 1,480.45 so far during the day.

The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016. The stock had underperformed the market over the past one month till 23 January 2017, advancing 2.57% compared with the Sensexs 4.13% rise. The scrip had, however, outperformed the market over the past one quarter, declining 1.09% as against the Sensexs 3.42% fall.

The large-cap company has equity capital of Rs 90.30 crore. Face value per share is Rs 2.

Lupin said it has launched its Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg in the United States having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals, Incs Ortho-Cyclen 28 Tablets (Norgestimate/Ethinyl Estradiol).

Lupins Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg are the AB rated generic equivalent of Janssen Pharmaceuticals, Inc.s Ortho-Cyclen 28 Tablets (Norgestimate/Ethinyl Estradiol). It is indicated for use by females of reproductive potential to prevent pregnancy.

Ortho-Cyclen 28 Tablets had annual US sales of $204 million as per IMS MAT September 2016.

Lupins consolidated net profit rose 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015. The company is scheduled to announce Q3 December 2016 results on 9 February 2017.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News

Volumes jump at Gujarat Gas counter
Jan 24,2017

Gujarat Gas clocked volume of 5.98 lakh shares by 14:01 IST on BSE, a 208.01-times surge over two-week average daily volume of 3,000 shares. The stock rose 2.70% to Rs 554.10.

Pidilite Industries notched up volume of 62.37 lakh shares, a 207.37-fold surge over two-week average daily volume of 30,000 shares. The stock rose 2.55% to Rs 644.30.

Astral Poly Technik saw volume of 2.54 lakh shares, a 102.95-fold surge over two-week average daily volume of 2,000 shares. The stock fell 0.26% to Rs 380.

Ajanta Pharma clocked volume of 4.39 lakh shares, a 66.93-fold surge over two-week average daily volume of 7,000 shares. The stock fell 5.19% to Rs 1,691.

Kotak Mahindra Bank saw volume of 44.72 lakh shares, a 51.74-fold rise over two-week average daily volume of 86,000 shares. The stock rose 1.18% to Rs 739.50.

Powered by Capital Market - Live News

BASF enters crop protect market in India
Jan 24,2017

BASF India has entered into crop protection market for Rice with the launch of two products Seltima and Adexar for Indian market. The Company would offer a wide range of new solutions to boost yields in India by managing rice diseases, weeds and pests.

Powered by Capital Market - Live News

BASF enters crop protect market in India
Jan 24,2017

BASF India has entered into crop protection market for Rice with the launch of two products Seltima and Adexar for Indian market. The Company would offer a wide range of new solutions to boost yields in India by managing rice diseases, weeds and pests.

Powered by Capital Market - Live News

Camson Bio Technologies appoints company secretary and compliance officer
Jan 24,2017

Camson Bio Technologies announced that the Company has appointed a Company Secretary and Compliance Officer, Anupriya Srivastava with effect from 23 January 2017.

Powered by Capital Market - Live News

Camson Bio Technologies appoints company secretary and compliance officer
Jan 24,2017

Camson Bio Technologies announced that the Company has appointed a Company Secretary and Compliance Officer, Anupriya Srivastava with effect from 23 January 2017.

Powered by Capital Market - Live News

Lupin launches Norgestimate and Ethinyl Estradiol Tablets
Jan 24,2017

Lupin has launched its Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals, Inc.s Ortho-Cyclenn++ 28 Tablets (Norgestimate/Ethinyl Estradiol).

Lupins Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg are the AB rated generic equivalent of Janssen Pharmaceuticals, Inc.s Ortho-Cyclenn++ 28 Tablets (Norgestimate/Ethinyl Estradiol). It is indicated for use by females of reproductive potential to prevent pregnancy.

Ortho-Cyclenn++ 28 Tablets had US sales of USD 204 million (IMS MAT September 2016).

Powered by Capital Market - Live News

Lupin launches Norgestimate and Ethinyl Estradiol Tablets
Jan 24,2017

Lupin has launched its Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals, Inc.s Ortho-Cyclenn++ 28 Tablets (Norgestimate/Ethinyl Estradiol).

Lupins Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg are the AB rated generic equivalent of Janssen Pharmaceuticals, Inc.s Ortho-Cyclenn++ 28 Tablets (Norgestimate/Ethinyl Estradiol). It is indicated for use by females of reproductive potential to prevent pregnancy.

Ortho-Cyclenn++ 28 Tablets had US sales of USD 204 million (IMS MAT September 2016).

Powered by Capital Market - Live News

Board of Western India Shipyard to review business
Jan 24,2017

Western India Shipyard announced that a Meeting of the Board of Directors of the Company will be held on 27 January 2017 at Mumbai to consider, inter-alia, the business progress of the Company.

Powered by Capital Market - Live News

Board of Western India Shipyard to review business
Jan 24,2017

Western India Shipyard announced that a Meeting of the Board of Directors of the Company will be held on 27 January 2017 at Mumbai to consider, inter-alia, the business progress of the Company.

Powered by Capital Market - Live News

Board of Bambino Agro Industries to consider Q3 and 9M results
Jan 24,2017

Bambino Agro Industries announced that the Meeting of Board of Directors of the Company will be held on 13 February 2017, inter alia, to consider, approve and take on record the un-audited financial results for the quarter/nine months ended 31 December 2016.

Powered by Capital Market - Live News

Board of Bambino Agro Industries to consider Q3 and 9M results
Jan 24,2017

Bambino Agro Industries announced that the Meeting of Board of Directors of the Company will be held on 13 February 2017, inter alia, to consider, approve and take on record the un-audited financial results for the quarter/nine months ended 31 December 2016.

Powered by Capital Market - Live News

Board of Electrosteel Steels to consider December quarter results
Jan 24,2017

Electrosteel Steels announced that a meeting of the Board of Directors of the Company will be held on 02 February 2017, inter alia, to consider, approve and take on record the un-audited Financial Results of the Company for the quarter and nine months ended 31 December 2016.

Powered by Capital Market - Live News

Board of Electrosteel Steels to consider December quarter results
Jan 24,2017

Electrosteel Steels announced that a meeting of the Board of Directors of the Company will be held on 02 February 2017, inter alia, to consider, approve and take on record the un-audited Financial Results of the Company for the quarter and nine months ended 31 December 2016.

Powered by Capital Market - Live News